The once-daily cream can be used anywhere on the body and ...
40 percent of children achieved complete skin clearance at week 16 ...
Risk reductions stronger in those with psoriasis versus those with obesity ...
It is the first topical JAK inhibitor approved in the U.S. ...
Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with ...
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions ...
Differences between adalimumab and other targeted treatments mainly not significant By ...
Patients with psoriatic arthritis are less likely to begin disease-modifying antirheumatic ...
Approval granted for adults and children 12 years and older who ...
Frequent treatment alterations of off-label biologics and nonsteroidal systemic agents observed ...